KLEVA Pharmaceuticals S.A.

KLEVA Pharmaceuticals S.A. is a privately owned pharmaceutical company established in Greece since 1974. The company specializes in commercializing proprietary prescription and OTC products and is rapidly evolving within the Greek pharmaceutical industry. KLEVA has proven success in developing generic pharmaceuticals at a European level and navigating regulatory approvals. The company operates as a fully integrated entity, encompassing R&D, RA, Production, QC, QA, Marketing, and Sales departments. With a state-of-the-art factory in Athens, equipped with the latest technology machinery and manufacturing potential for a wide range of pharmaceutical forms, KLEVA adheres strictly to GMPs specifications, WHO regulations, and holds ISO 9001-2008 TUV Austria Certification. Focused primarily on Pharmaceuticals (Rx & OTC), KLEVA offers flexible, scalable, qualitative, and cost-effective product development in a variety of dosage forms. The company is engaged in registering and exporting products to a number of regulated and non-regulated markets globally. KLEVA is actively seeking new market penetration, international business development opportunities, and contract manufacturing deals for Rx, OTC, and Food Supplement products. Overall, KLEVA Pharmaceuticals S.A. is a notable player in the Health Care, Manufacturing, and Pharmaceutical industries, with a strong foothold in Greece as its headquarters. With its established track record and ambitious growth objectives, the company presents attractive investment potential for Venture capital seeking opportunities in the pharmaceutical sector.